GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 105 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,761,909,000 | +59.8% | 73,720 | -2.4% | 0.00% | 0.0% |
| Q4 2020 | $1,102,622,000 | -2.4% | 75,522 | -5.1% | 0.00% | 0.0% |
| Q3 2020 | $1,129,894,000 | +0.2% | 79,570 | +3.8% | 0.00% | 0.0% |
| Q2 2020 | $1,128,139,000 | +306.0% | 76,692 | +13.7% | 0.00% | – |
| Q1 2020 | $277,853,000 | +5.1% | 67,440 | +22.7% | 0.00% | – |
| Q4 2019 | $264,424,000 | -22.7% | 54,974 | -2.6% | 0.00% | – |
| Q3 2019 | $341,870,000 | +1.4% | 56,414 | +8.6% | 0.00% | – |
| Q2 2019 | $337,130,000 | +12.1% | 51,946 | +22.4% | 0.00% | – |
| Q1 2019 | $300,806,000 | -0.9% | 42,427 | -32.1% | 0.00% | – |
| Q4 2018 | $303,653,000 | -33.9% | 62,480 | 0.0% | 0.00% | – |
| Q3 2018 | $459,229,000 | +5.4% | 62,480 | -8.5% | 0.00% | – |
| Q2 2018 | $435,671,000 | +62.1% | 68,287 | +38.2% | 0.00% | – |
| Q1 2018 | $268,736,000 | +30.5% | 49,400 | 0.0% | 0.00% | – |
| Q4 2017 | $205,998,000 | -8.6% | 49,400 | +111.1% | 0.00% | – |
| Q3 2017 | $225,342,000 | -18.6% | 23,400 | 0.0% | 0.00% | – |
| Q2 2017 | $276,822,000 | +114763.9% | 23,400 | +14.7% | 0.00% | – |
| Q3 2016 | $241,000 | +95.9% | 20,400 | +44.7% | 0.00% | – |
| Q2 2016 | $123,000 | +66.2% | 14,100 | 0.0% | 0.00% | – |
| Q1 2016 | $74,000 | -32.1% | 14,100 | 0.0% | 0.00% | – |
| Q4 2015 | $109,000 | -1.8% | 14,100 | 0.0% | 0.00% | – |
| Q3 2015 | $111,000 | -13.3% | 14,100 | 0.0% | 0.00% | – |
| Q2 2015 | $128,000 | -30.1% | 14,100 | 0.0% | 0.00% | – |
| Q1 2015 | $183,000 | +0.5% | 14,100 | +5.2% | 0.00% | – |
| Q4 2014 | $182,000 | +51.7% | 13,400 | 0.0% | 0.00% | – |
| Q3 2014 | $120,000 | -33.7% | 13,400 | 0.0% | 0.00% | – |
| Q2 2014 | $181,000 | – | 13,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|